COMPASS: Community Participation Transition After Stroke

Sponsor
Washington University School of Medicine (Other)
Overall Status
Completed
CT.gov ID
NCT02396589
Collaborator
(none)
15
1
2
22.8
0.7

Study Details

Study Description

Brief Summary

Stroke is one of the most serious, disabling health conditions in the United States. Patients who undergo rehabilitation treatment for stroke have a high rate of disability. Poor outcomes for many persons with stroke may be low because of incomplete treatment. The investigators will conduct a randomized controlled trial and a process evaluation to examine the feasibility, safety, and preliminary efficacy of an enhanced rehabilitation transition program, Community Participation Transition after Stroke (COMPASS), designed to bridge inpatient rehabilitation and the home to support the performance of everyday activities.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Education Group
  • Behavioral: Home Modifications Group
N/A

Detailed Description

We propose an enhanced rehabilitation transition program: Community Participation Transition after Stroke (COMPASS) is a compensatory intervention consisting of one pre-discharge and five post-discharge home visits by an occupational therapist to supplement usual care. This intervention is focused on resolving barriers to independence in daily activities and participation using environmental support and active practice of daily activities in an individual's real home (versus an idealized clinical setting). This is a new combination of evidence-based compensatory treatments delivered in a novel treatment setting (transition to home). Our long-term goal is the development of an effective intervention for a transition home designed to prevent excess disability for people living with stroke that could have an immediate effect and high public health significance.16

We will recruit 40 patients currently undergoing inpatient rehabilitation (IR) for ischemic stroke from longitudinal studies of stroke at Washington University School of Medicine (WUSM) and randomize them to receive six additional sessions of the enhanced rehabilitation transition program or attention control. Exploratory participation outcomes will be assessed by blinded evaluators at baseline, 6 months, 9 months, and 12 months after stroke.

We will test the central hypothesis that COMPASS will be acceptable, feasible, and superior to attention control on measures of participation and daily activity performance at 6 months after stroke.

Study Design

Study Type:
Interventional
Actual Enrollment :
15 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Feasibility of a Novel Intervention to Improve Participation After Stroke
Actual Study Start Date :
Jan 19, 2015
Actual Primary Completion Date :
Dec 13, 2016
Actual Study Completion Date :
Dec 13, 2016

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Education Group

Participants in the Education group receive five 90 minute tailored stroke education sessions in the home.

Behavioral: Education Group
Attention will be provided to the control group to ensure they experience the same effects of time and attention but no effect on the outcome of interest.

Experimental: Home Modifications Group

Participants in the treatment group receive a home assessment and home modifications tailored to functional abilities (pre discharge) and then five 90 minute occupational therapy treatment sessions at home (post discharge) to improve functional abilities and community participation.

Behavioral: Home Modifications Group
The standardized components include assessment, identification of five problematic activities (and environmental barriers), identification of three solutions (for each problem), implementation of a solution set selected by the participant, training, and active practice of daily activities in one's own home and community.

Outcome Measures

Primary Outcome Measures

  1. Measuring the Safety of the intervention (rate and severity of falls (calculated with an algorithm) [12 months]

    We will explore the safety of the intervention by determining the rate and severity of falls (calculated with an algorithm).

Secondary Outcome Measures

  1. Measuring the intervention dose [2 months]

    Calculating the intervention received by both groups (number of minutes and number of sessions delivered).

  2. Measuring health care utilization [12 months]

    We will also examine health care utilization (emergency department and outpatient visits, number of hospitalizations, and days hospitalized) for both groups.

Other Outcome Measures

  1. Measuring adherence to the intervention [6 months]

    Interventionists will rate adherence at visit 6, as the number of recommendations implemented per recommendations suggested. Long-term adherence will be calculated as the number of recommendations used at 6 months per recommendations suggested. We will examine reasons for abandonment of strategies (resolved motor skills will not count against adherence score).

Eligibility Criteria

Criteria

Ages Eligible for Study:
45 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. ≥45 years old

  2. acute ischemic stroke, verified by a neurologist

  3. baseline National Institutes of Health Stroke Scale (NIHSS) ≥8

  4. independent in activities of daily living prior to stroke (premorbid Rankin score of ≤2)

  5. plan to discharge to home

Exclusion Criteria:
  1. severe terminal systemic disease that limits life expectancy to <6 months

  2. previous disorder (e.g., dementia) that makes interpretation of the self-rated scales difficult or a Short Blessed Test (SBT) score of ≥9 (indicating significant cognitive impairment)

  3. moderate to severe aphasia, as determined by the NIHSS Best Language rating of ≥2

  4. residence in a congregate living facility

  5. not eligible for a therapeutic pass

Contacts and Locations

Locations

Site City State Country Postal Code
1 Washington University School of Medicine Saint Louis Missouri United States 63110

Sponsors and Collaborators

  • Washington University School of Medicine

Investigators

  • Principal Investigator: Susan L Stark, PhD, Washington University School of Medicine, Program in Occupational Therapy

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Susan Stark, Assisstant Professor of Neurology and Occupational Therapy, Washington University School of Medicine
ClinicalTrials.gov Identifier:
NCT02396589
Other Study ID Numbers:
  • NCMRR 1611R03HD079841-01A1
First Posted:
Mar 24, 2015
Last Update Posted:
Apr 24, 2018
Last Verified:
Apr 1, 2018
Keywords provided by Susan Stark, Assisstant Professor of Neurology and Occupational Therapy, Washington University School of Medicine
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 24, 2018